Sponsor or institution

Clinical trials and research at Chinese PLA General Hospital

• 133Clinical trials
• 5New in 30 days
• 1Country

Newest trials

All recruiting trials (133)

• CD19 and CD22 in vivo CAR-T therapy for relapsed/refractory B-ALL

  This study tests a one-of-a-kind in vivo CAR-T treatment that targets CD19 first and then CD22 in adults with relapsed or refractory B-ALL to see if it is safe and possibly effective.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07927816

• Romiplostim to help platelets grow after donor stem cell transplant

  This phase II trial tests whether weekly romiplostim helps patients over 18 who receive a haploidentical or fully matched unrelated donor stem cell transplant to engraft platelets faster than best supportive care.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07919977

• Exercise effect on the lumbar multifidus in back pain

  This study tests whether a 12-week home rehab program can change ultrasound features of the lumbar multifidus and reduce pain in adults with chronic non-specific low back pain from multifidus injury.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07892846

• Can preoperative photon-counting CT help predict heart recovery after bypass surgery?

  This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07883499

• BEX101 CAR-T at the bedside for relapsed or refractory B-cell NHL

  A bedside, on-site CAR-T therapy called BEX101 is being tested in adults with relapsed or refractory B-cell non-Hodgkin’s lymphoma to see if it is safe and can help control the disease.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07882641

• Population PK-guided ATG Dosing in Haploidentical Stem Cell Transplant

  This trial tests a population PK-guided ATG dosing strategy in people undergoing haploidentical hematopoietic stem cell transplantation to see if it improves outcomes.

  Recruiting Phase 3 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07862127

• Mn2+-primed immunochemotherapy in advanced ovarian cancer

  This trial tests whether adding manganese chloride to an anti-PD-1 antibody plus chemotherapy helps patients with advanced ovarian cancer who have already had multiple treatments.

  Recruiting at 3 sites Phase 3 Chinese PLA General Hospital · Beijing, Beijing Municipality and 5 other locations · NCT07822646

• Sodium Oxybate to Improve Sleep After Thoracic Surgery

  In adults having elective thoracoscopic surgery, this study tests whether giving sodium oxybate during operation improves sleep quality after surgery compared with a placebo.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07794982

• Population PK-guided ATG Dosing in Haplo-HSCT

  This study tests a population PK-guided dosing strategy for anti-thymocyte globulin (ATG) in adults and adolescents undergoing haploidentical stem cell transplantation to see if it can reduce GVHD while keeping relapse risk acceptable.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07791576

• CD19/CD22 CAR-T consolidation after second-line therapy for high-risk aggressive B-cell lymphoma

  This trial tests whether CD19/CD22 CAR-T cell therapy given after a second-line response can help people with high-risk aggressive B-cell lymphoma stay in remission.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07779018

• Cryoablation for Thyroid Tumors: Is It Safe and Effective?

  This study tests whether cryoablation can shrink thyroid tumors and be safe, using ultrasound guidance in people with small papillary thyroid cancers or benign nodules.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07776262

• In Vivo CD19/CD20 CAR T-Cell Therapy for Relapsed or Refractory B-Cell Lymphoma

  This early-phase trial tests a one-time in vivo CAR T-cell therapy (SL1617) for people with relapsed or refractory B-cell lymphoma to see if it is safe and tolerable.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing · NCT07775508

• Cold-region exposure and heart remodeling after PCI

  This study tests whether long-term cold exposure before PCI is linked to worse heart remodeling and outcomes in people with coronary artery disease.

  Recruiting Chinese PLA General Hospital · Beijing, Please Select An Option Below · NCT07773870

• Photon-counting CT to check intracranial stents

  This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07769814

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

• Noninvasive Imaging of Intracranial Venous Sinus Stents with Ultra-High-Resolution Photon-Counting CT Angiography

  This study tests whether ultra-high-resolution photon-counting CT angiography can better visualize intracranial venous sinus stents and reduce metal-related artifacts in adults who have had stents.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07762677

• Photon-counting CT vs conventional CT for carotid plaque in people with carotid artery stenosis

  This study tests whether photon-counting CT gives clearer, more detailed pictures of carotid plaques compared with standard CT in patients with carotid artery stenosis to help characterize plaque features.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07762664

• Obinutuzumab beta with low-dose steroids in new-onset ANCA-associated glomerulonephritis

  This study tests whether adding Obinutuzumab beta to a rapid-tapering glucocorticoid plan can help people with new-onset ANCA-associated glomerulonephritis see if they achieve remission.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07746180

• Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients

  This study tests whether the 2025 ASAS-SPARTAN criteria correctly classify axial spondyloarthritis in adults with chronic back pain in China.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07724847

• H. pylori status and tissue features to predict gastric cancer behavior after endoscopic treatment

  This study tests whether current H. pylori infection status and tissue features can help predict how early gastric cancer will behave after endoscopic treatment.

  Recruiting at 3 sites Chinese PLA General Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07724496

• Exosome therapy for male pattern baldness

  This trial tests whether injecting hUCMSC-derived exosomes into the scalp can promote hair regrowth in men with androgenetic alopecia, compared with a placebo.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07693244

• Blinatumomab plus low-dose donor cells after transplant for high-risk B-ALL

  This small, early-phase study tests whether giving blinatumomab with low-dose donor lymphocytes after allogeneic transplant is safe and helps long-term survival for people with high-risk B-ALL.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing · NCT07677878

• Personalized ATG dosing in unrelated donor stem cell transplants

  This trial tests whether tailoring anti-thymocyte globulin dosing works better than standard fixed dosing in adults and adolescents receiving unrelated donor stem cell transplants.

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07648992

• Allogeneic CD70 CAR-T Therapy for Unresectable or Metastatic Clear Cell RCC

  This trial tests ET-970, a donor-derived CD70 CAR-T cell therapy, to see if it is safe and shows signs of effectiveness in people with unresectable or metastatic clear cell renal cell carcinoma.

  Recruiting at 3 sites Early Phase 1 Chinese PLA General Hospital · Beijing and 2 other locations · NCT07645690

• Placental-derived 3D mesenchymal stem cells for acute ischemic stroke

  A Phase 1/2a trial tests whether a single intravenous dose of human placenta-derived 3D mesenchymal stem cells can be given safely to adults who recently had an ischemic stroke and whether it shows early signs of benefit.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing · NCT07635758

• KSVCBD Injection for B-cell Non-Hodgkin's Lymphoma with CD19 and/or BCMA

  This study tests KSVCBD, a CAR-T therapy made inside the body, in adults with relapsed or refractory B-cell non-Hodgkin's lymphoma to see if it is safe and can help fight the cancer.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07620314

• KSVCBD injection for relapsed or refractory multiple myeloma with CD19 and/or BCMA

  A one-arm, early-phase trial tests KSVCBD injection, a CAR-T therapy that targets CD19 and BCMA, in adults with relapsed or refractory multiple myeloma expressing CD19 and/or BCMA to see if it is safe and shows signs of effectiveness.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07620275

• Dapagliflozin to slow coronary plaque progression in type 2 diabetes

  This trial tests whether adding dapagliflozin to standard care can slow or reverse coronary plaque buildup in adults with type 2 diabetes and stable coronary disease.

  Recruiting at 2 sites Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07614230

• CD19/CD22 CAR-T as first-line consolidation for follicular lymphoma

  This trial tests whether CAR-T cells targeting CD19 and CD22 can be used as a first-line consolidation therapy for people with follicular lymphoma to see if it improves outcomes.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07587840

• In Vivo BCMA/GPRC5D Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

  A first-in-human, single-center study tests a two-target CAR-T cell therapy given in vivo to see if it is safe and tolerable in adults with relapsed or refractory plasma cell neoplasms.

  Recruiting Early Phase 1 Chinese PLA General Hospital · Beijing · NCT07586709

• Early budesonide capsules plus standard care for IgA nephropathy

  This study tests whether adding budesonide enteric-coated capsules alongside routine blood pressure and glucose-lurine control helps reduce protein in adults with primary IgA nephropathy.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07585981

• Ultra-minimally invasive prostate balloon dilation for men with BPH and significant obstruction

  This study tests whether transrectal ultrasound–guided ultra-minimally invasive prostate balloon dilation can reduce urinary symptoms in men aged 40–80 with BPH and significant bladder outlet obstruction.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07583706

• Dual-target CD22/CD19 CAR-T consolidation after first remission in high-risk B-ALL

  This test will try a dual-target CD22/CD19 CAR-T cell treatment as consolidation for patients with high-risk B-cell acute lymphoblastic leukemia who are in their first remission.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07575971

• CD22/CD19 CAR-T consolidation for adults with standard-risk B-ALL

  This study will try dual-target CD22/CD19 CAR-T cell therapy as a consolidation treatment for adults with standard-risk B-cell acute lymphoblastic leukemia who are in first remission.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07575919

• QH101 Vδ2 T-cell therapy for adults with relapsed or advanced malignant tumors

  This study will try QH101, an off-the-shelf Vδ2 T-cell therapy, in adults with relapsed or advanced blood cancers or solid tumors to see if it is safe and helps fight tumors.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07570563

• Thermal ablation plus antithyroid medication for primary hyperthyroidism

  This trial tests whether adding thermal ablation to antithyroid drugs helps people with primary hyperthyroidism get faster symptom relief and fewer complications long term.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07557810

• Camrelizumab with long-course chemoradiotherapy before surgery for locally advanced low rectal cancer (pMMR/MSS)

  This trial tests whether giving camrelizumab before and after long-course chemoradiotherapy helps people with locally advanced, pMMR/MSS low rectal cancer achieve a higher complete response and preserve the rectum.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07527026

• Venetoclax with azacitidine, chidamide and CAG chemotherapy for fit older adults with AML

  This will test whether adding venetoclax and chidamide to azacitidine plus CAG chemotherapy helps people aged 60-75 with newly diagnosed AML achieve remission more often than the standard 3+7 regimen.

  Recruiting Phase 3 Chinese PLA General Hospital · Beijing, None Selected · NCT07514936

• Venetoclax plus CACAG versus 3+7 for acute monocytic leukemia

  This trial will test whether adding venetoclax to a CACAG combination works better than standard 3+7 chemotherapy for people aged 14–60 with acute monocytic leukemia.

  Recruiting at 3 sites Phase 2 Chinese PLA General Hospital · Beijing and 2 other locations · NCT07512700

• Combining ruxolitinib with corticosteroids for severe acute graft‑versus‑host disease

  This trial tests whether adding ruxolitinib to corticosteroids as first‑line treatment helps people who develop severe acute graft‑versus‑host disease after a first stem cell transplant.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07509749

• Combining CAR‑T therapy with chidamide and a PD‑1 blocker for B‑cell lymphoma

  This Phase 2 trial will try adding chidamide and a PD‑1 inhibitor as maintenance after CAR‑T therapy for people with relapsed or high‑risk diffuse large B‑cell lymphoma.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07489989

• PD-1Ab21-BCMA CAR-T consolidation for multiple myeloma with renal dysfunction

  This trial will test a BCMA-targeted CAR-T cell therapy that secretes a PD-1 antibody and interleukin-21 fusion protein as consolidation treatment for people with multiple myeloma who have kidney dysfunction.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07489534

• EBV-specific T-cell infusions for EBV-positive lymphoma and PTLD

  This trial will test whether infusions of EBV-specific cytotoxic T cells (EBV-AST) are safe and can help adults with EBV-associated lymphoproliferative disorders, including post-transplant lymphoproliferative disease and EBV-positive lymphomas.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07450391

• EBV-AST cell infusion for treating EBV-DNA viremia after allogeneic stem cell transplant.

  This will test if infusions of EBV-targeted immune cells (EBV-AST) can lower EBV-DNA levels in adults who develop EBV viremia after an allogeneic stem cell transplant.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing · NCT07438067

• Acute treatments for AQP4-positive NMOSD attacks

  This project will test whether adding eculizumab or IVIG to high-dose IV steroid pulses helps adults with AQP4-positive NMOSD during an acute attack.

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing · NCT07410039

• OLE airway clearance with EIT monitoring for ICU patients with pneumonia

  This tests whether Oscillatory Lung Expansion (OLE) airway clearance, monitored with electrical impedance tomography (EIT), helps adult ICU patients with pulmonary infections clear secretions and improve cough strength.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07395297

• Tailored hydration using ReDS lung‑water monitoring to prevent kidney injury during coronary angiography and intervention

  This trial tests whether using a ReDS lung‑water monitor to guide IV fluids can lower the risk of contrast‑induced acute kidney injury in people aged 60 and older with reduced kidney function having coronary angiography or PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07394959

• Fruquintinib plus nab‑paclitaxel with iparomlimab and tuvonralimab for people with advanced gastric or GEJ cancer after immunotherapy

  This trial tests whether adding fruquintinib and two immune drugs (iparomlimab and tuvonralimab) to nab‑paclitaxel helps people with advanced gastric cancer whose disease progressed after first‑line immunotherapy.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07392346

• First-line treatment of advanced colorectal cancer using simultaneous levofolinate and 5‑FU infusion

  This trial will try combining simultaneous infusion of levofolinate (levozolinate) with 5‑FU as first-line chemotherapy for adults with unresectable or metastatic colorectal cancer.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07391618

• EBV-targeted T-cell therapy for persistent EBV DNAemia after allogeneic transplant

  This treatment will try infusing EBV-specific TCR-engineered T cells into adults with persistent or rising EBV DNA after an allogeneic stem cell transplant to see if the virus clears and the therapy is safe.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing · NCT07368634

• First-line ruxolitinib plus corticosteroids for grade II acute graft-versus-host disease

  This trial will test whether adding ruxolitinib to standard corticosteroids helps people with new grade II acute graft-versus-host disease after an allogeneic stem cell transplant.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07340723

• Nanoparticle-delivered CAR1920 mRNA CAR‑T targeting CD19 and CD20 for relapsed or refractory B‑cell lymphoma/leukemia

  This trial tests whether polymer-lipid nanoparticles can deliver CAR1920 mRNA to program a patient's T cells to target CD19 and CD20 in people with relapsed or refractory B‑cell lymphoma or leukemia.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07321301

• RAK cell therapy for late-stage gastric cancer

  This study will test whether umbilical cord blood–derived RAK cell therapy can help adults with late-stage or recurrent gastric cancer live longer and tolerate treatment after frontline therapies have failed.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07212933

• Anti-BCMA-CD19 CAR-T therapy for relapsed or refractory IgG4-related disease

  This trial will test a personalized CAR-T cell therapy that targets BCMA and CD19 in adults (18–75) whose IgG4-related disease has come back or not responded to standard treatments like steroids or rituximab.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07148791

• Eliglustat combined with CD30-targeted therapy for CD30+ lymphoma

  This study tests whether adding eliglustat to CD30-targeted treatments (such as brentuximab vedotin or CD30 CAR‑T) helps people with CD30-positive lymphoma.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07138547

• Personalized ceftobiprole dosing for older adults guided by blood levels

  This study tests whether individualized dosing of ceftobiprole, guided by blood level measurements and patient factors, can improve treatment accuracy for people aged 60 and older.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07127185

• Ruxolitinib plus decitabine intensified conditioning for AML patients having allogeneic stem cell transplant

  This trial will see if adding ruxolitinib and decitabine to standard busulfan-based conditioning before allogeneic HSCT lowers relapse in high‑risk AML patients in first complete remission (CR1).

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07101588

• Treating metastatic prostate cancer with [177Lu] Lu-PSMA-XT injection

  This trial tests a radioactive PSMA-targeting injection called [177Lu] Lu-PSMA-XT in men with metastatic castration-resistant prostate cancer to see if it is safe, tolerable, and can help control the cancer.

  Recruiting at 3 sites Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07096128

• Deep brain stimulation and neck lymphatic‑venous bypass for severe Alzheimer's disease

  This project tests deep brain stimulation plus a neck lymphatic‑venous bypass to see if they are safe and help thinking, mood, and quality of life in people with severe Alzheimer's disease.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing · NCT07094438

• Alzheimer's Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER) cohort

  This project will use 3T and 7T MRI, blood biomarkers, and genetic testing to try to find early brain and sodium changes in people aged 55–90 who are cognitively normal, have mild cognitive impairment, or have Alzheimer's.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07089303

• AI-guided hematoma aspiration versus conservative drug therapy for spontaneous intracerebral hemorrhage

  This trial will test whether AI-assisted, navigation-guided hematoma aspiration or targeted pharmacological therapy leads to better recovery for people with moderate-volume spontaneous supratentorial intracerebral hemorrhage.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07077343

• Using cardiac MRI and AI to predict outcomes after STEMI

  This project will try to use routine cardiac MRI scans plus AI to see if imaging features can predict long-term outcomes in people who had a STEMI treated with primary PCI.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07072858

• PET imaging with 68Ga-XT771 to detect CAIX/CAXII in glioblastoma and clear cell renal cell carcinoma

  This trial tests whether a PET probe called 68Ga-XT771 can help find CAIX/CAXII-expressing glioblastoma and clear cell renal cell carcinoma in adults.

  Recruiting Early Phase 1 Chinese PLA General Hospital · Beijing · NCT07067905

• Switching to pegmolesatide for anemia in people on dialysis

  This 24-week test will try whether switching dialysis patients whose anemia isn't at goal from rHuEPO to pegmolesatide alone or combined with roxadustat keeps or raises hemoglobin better than continuing rHuEPO.

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07045155

• Staged dual-target MR-guided focused ultrasound (VIM + PTT) for Parkinson's motor symptoms

  This will test whether a staged, dual-target MR-guided focused ultrasound procedure (targeting VIM and PTT) can safely reduce disabling, largely one-sided motor symptoms in people with levodopa-responsive Parkinson's disease.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07044973

• Irinotecan liposome combined with cetuximab and bevacizumab for irinotecan-resistant metastatic colorectal cancer

  This trial will test whether combining irinotecan liposomes with cetuximab and bevacizumab can shrink tumors or slow growth in people with metastatic colorectal cancer that no longer responds to irinotecan.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT07044921

• PIN plus anti‑PD‑1 for previously treated advanced liver cancer

  This trial tests whether adding a new oncolytic virus called PIN to anti‑PD‑1 therapy can help people with advanced liver cancer after other treatments have stopped working.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital · NCT07018518

• Wearable ultrasound sensors for early diagnosis and real-time monitoring

  This project will try a wearable ultrasound sensor to detect and monitor blood clots, heart-failure changes, and continuous bedside issues in ICU patients.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07009873

• BCOR and ZC3H12 knockout CD19 CAR-T therapy for relapsed/refractory B‑cell lymphoma

  This will try an autologous CD19 CAR‑T treatment with two genes (BCOR and ZC3H12) turned off to see if it works better for adults whose B‑cell lymphoma has returned or not responded to prior treatments.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07009002

• BCOR and ZC3H12 gene‑knockout CD19 CAR‑T therapy for adults with relapsed/refractory B‑cell ALL

  This will test whether autologous CD19‑targeting CAR‑T cells with BCOR and ZC3H12 genes knocked out can be safe and produce durable remissions in adults with relapsed or refractory B‑cell acute lymphoblastic leukemia.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Biotherapeutic Department of Chinese PLA General Hospital and 1 other locations · NCT07008885

• Amimestrocel (umbilical cord mesenchymal stromal cells) for diabetic kidney disease

  This trial will test whether umbilical cord-derived mesenchymal stromal cells (Amimestrocel) can improve kidney function or reduce protein in adults with progressive diabetic kidney disease.

  Recruiting at 5 sites Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 5 other locations · NCT06969807

• Amimestrocel (umbilical cord mesenchymal stromal cells) for acute kidney injury

  This trial tests whether Amimestrocel (umbilical cord mesenchymal stromal cells) can help adults aged 18–75 with acute kidney injury recover kidney function while monitoring safety.

  Recruiting at 5 sites Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 5 other locations · NCT06954740

• Personalized neoantigen mRNA vaccine for rhabdomyosarcoma

  A personalized mRNA vaccine, given with an anti-PD-1 antibody and CpG adjuvant, is being tested in patients with refractory rhabdomyosarcoma to see if it can help prolong life.

  Recruiting Early Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06932861

• Comparing two treatment regimens for newly diagnosed acute myeloid leukemia

  This study is testing a new treatment for people with newly diagnosed acute myeloid leukemia to see if it works better than the standard treatment.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06928376

• Combining PIN with anti-PD1 for advanced solid tumors

  This study is testing a new virus treatment combined with anti-PD1 therapy to see if it can help patients with advanced solid tumors who haven't responded to other treatments.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06883149

• A system for preventing and controlling diabetic nephropathy

  This study is trying to create a system to better understand and manage diabetic nephropathy by collecting data on risk factors and symptoms from a large group of people with diabetes.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06843304

• Allogeneic CD19-targeting CAR-γδT cell therapy (QH103E) for relapsed or refractory B‑cell non-Hodgkin lymphoma.

  This will try an off-the-shelf, gene-edited CD19-directed CAR-γδT cell infusion (QH103E) in adults with relapsed or refractory B‑cell non-Hodgkin lymphoma.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06838832

• Immunotherapy using modified NK cells for treating relapsed or refractory AML

  This study is testing a new treatment using modified immune cells to see if it can help people with relapsed or hard-to-treat Acute Myeloid Leukemia feel better and achieve remission.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, China · NCT06835140

• MRI/TRUS fusion–guided thermal vapor ablation for benign prostatic enlargement

  This will try a targeted steam (thermal vapor) treatment guided by MRI and ultrasound to reduce urinary symptoms in men 45–85 with moderate to severe BPH who have not responded to or declined medications.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06817733

• Combination treatment for advanced pancreatic cancer

  This study is testing a new combination of treatments for advanced pancreatic cancer to see if it works better than another option for patients who haven't had success with their first treatment.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing and 1 other locations · NCT06782685

• Evaluating early lipid-lowering therapy in acute coronary syndrome patients

  This study is testing if starting a new cholesterol-lowering treatment early can help Chinese patients with acute coronary syndrome have better heart health and lower cholesterol levels compared to other treatments.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06738758

• Using ultrasound to treat recurrent thyroid cancer

  This study is testing if using ultrasound to heat and destroy recurrent thyroid cancer can be a safe and effective treatment for patients who have already had surgery for their thyroid cancer.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06733766

• Ultrasound-guided thermal ablation for certain thyroid nodules

  This study tests whether a special heat treatment using ultrasound can safely help people with certain thyroid nodules who can't or don't want to have surgery.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06733753

• Ultrasound-guided thermal ablation for treating papillary thyroid cancer

  This study is testing whether ultrasound-guided thermal ablation can safely and effectively treat small papillary thyroid cancers in patients with less aggressive disease over a follow-up period of at least a year.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06733740

• Ultrasound-guided thermal ablation for benign thyroid nodules

  This study tests whether a new ultrasound-guided heat treatment can safely shrink benign thyroid nodules and improve patients' experiences over a year.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06729762

• Sliding compression locking plate to fix fresh femoral neck fractures

  This trial tests whether a sliding compression locking plate is safe and works well for adults with fresh femoral neck fractures who need internal fixation.

  Recruiting at 2 sites Chinese PLA General Hospital · Beijing, Beijing Municipality and 2 other locations · NCT06713291

• Combining Surufatinib with Gemcitabine, Cisplatin, and Durvalumab/Pembrolizumab for Advanced Biliary Tract Cancer

  This study is testing if adding a new drug called surufatinib to the standard treatment for advanced biliary tract cancer can help patients live longer and feel better.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06708858

• Combining Fruquintinib, Chidamide, and Sintilimab for Advanced Colorectal Cancer Treatment

  This study is testing a new combination of three drugs to see if it can help people with advanced colorectal cancer that hasn't improved with other treatments.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06685276

• Individualized ATG dosing for stem cell transplantation

  This study is testing a personalized approach to dosing a medication for adults receiving stem cell transplants to see if it can reduce complications like infections and improve recovery.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06572462

• Evaluating the invasiveness of liver cancer using imaging techniques

  This study is testing whether non-invasive imaging can help doctors understand how aggressive liver cancer is in patients who can't have surgery.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06559761

• GSL synthetase inhibitor with immunotherapy and/or regorafenib for previously treated pMMR/MSS colorectal cancer

  This trial will test whether adding a GSL synthetase inhibitor to an immune checkpoint blocker, with or without regorafenib, helps people with previously treated pMMR/MSS metastatic colorectal cancer.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital · NCT06558773

• Protecting kidney function using remote ischemic conditioning in chronic kidney disease patients

  This study is testing if a new method called remote ischemic conditioning can help protect kidney function in people with chronic kidney disease.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06501222

• Gene Knock-out CAR-T Cell Therapy for Acute Lymphocytic Leukemia

  This study is testing a new type of CAR-T cell therapy to see if it can help people with hard-to-treat B-cell acute lymphoblastic leukemia feel better and fight their cancer.

  Recruiting at 5 sites Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 5 other locations · NCT06481735

• Combining three medications for untreated follicular lymphoma

  This study is testing a new combination of three medications to see if they can effectively treat people with untreated follicular lymphoma without using traditional chemotherapy.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06471738

• Comparing microwave ablation and liver surgery for treating intrahepatic cholangiocarcinoma

  This study is testing whether microwave ablation can be a good first treatment option for people with a specific type of liver cancer compared to traditional liver surgery.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06462742

• Using advanced MRI to study Parkinson's disease

  This study is testing advanced MRI technology to see how it can help us understand the differences in brain images of people with early-stage Parkinson's disease compared to healthy individuals.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing, China · NCT06449404

• Combination treatment for patients with relapsed classical Hodgkin lymphoma who can't undergo transplant

  This study is testing a new combination treatment for patients with relapsed classical Hodgkin lymphoma who can't have a transplant to see if it helps them live longer without their cancer getting worse.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06393361

• Understanding lower urinary tract symptoms in Chinese men

  This study looks at how common lower urinary tract symptoms are in Chinese men and what factors might be linked to these symptoms, while also checking how many men are getting treated for them.

  Recruiting Chinese PLA General Hospital · Beijing · NCT06352736

• Evaluating ultrasound-guided thermal ablation for benign thyroid nodules

  This study is testing if a new ultrasound-guided treatment can safely shrink benign thyroid nodules and help people feel better.

  Recruiting Chinese PLA General Hospital · Beijing · NCT06340945

• Gene knock-out CAR-T cell therapy for B cell lymphoma

  This study is testing a new CAR-T cell therapy for people with hard-to-treat B cell lymphoma to see if it is safe and effective.

  Recruiting at 3 sites Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 2 other locations · NCT06323525

• New T Cell Therapy for Relapsed B-Cell Non-Hodgkin Lymphoma

  This study is testing a new T cell therapy for people with relapsed B-cell non-Hodgkin lymphoma to see if it can help fight their cancer while reducing side effects.

  Recruiting at 2 sites Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06321289

• Evaluating thermal ablation and surgery for low-risk papillary thyroid cancer

  This study is testing whether a new treatment using heat can be as effective as traditional surgery for people with low-risk thyroid cancer.

  Recruiting Chinese PLA General Hospital · Beijing · NCT06316895

• Evaluating [177Lu]Lu-XT117 Injection for Advanced Solid Tumors

  This study is testing a new injection for people with advanced solid tumors that haven't responded to other treatments to see if it's safe and effective.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing · NCT06211647

• Analyzing the relationship between gut bacteria and immune response in patients with a specific type of dermatomyositis and lung disease

  This study is trying to see how the bacteria in the gut affect the immune system in patients with a specific type of skin and lung disease.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06203249

• Using EBV-TCR-T cells to treat EBV-related conditions

  This study is testing a new treatment using special immune cells to see if it can help people with serious conditions related to the Epstein-Barr virus.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06135922

• Using engineered T cells to treat EBV infection after stem cell transplant

  This study is testing a new treatment using specially modified T cells to help patients who have developed Epstein-Barr virus infection after a stem cell transplant.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06119256

• Combining Venetoclax with CACAG regimen for treating relapsed/refractory acute myeloid leukemia

  This study is testing a new treatment that combines venetoclax with a specific drug regimen to see if it helps people with relapsed or refractory acute myeloid leukemia feel better compared to the best available therapy.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06084819

• Allogeneic CAR-T cell therapy for relapsed or refractory B-cell non-Hodgkin's lymphoma

  This study is testing a new CAR-T cell therapy to see if it can help people with hard-to-treat B-cell non-Hodgkin's lymphoma feel better and have more treatment options.

  Recruiting at 3 sites Phase 1/2 Chinese PLA General Hospital · Beijing and 2 other locations · NCT06014073

• CD70 targeted CAR-T cell therapy for lymphoma

  This study is testing a new type of CAR-T cell therapy aimed at helping patients with lymphoma that hasn't responded to other treatments.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital · NCT05948033

• CD70 targeted CAR-T cell therapy for advanced solid tumors

  This study is testing a new type of CAR-T cell therapy that targets CD70 to see if it can help people with advanced solid tumors feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Iotherapeutic Department of Chinsese PLA Gereral Hospital · NCT05947487

• New methods for diagnosing and treating type 2 diabetes nephropathy

  This study is testing new ways to diagnose and treat kidney problems in people with type 2 diabetes by using advanced tools and combining different medical approaches.

  Recruiting Chinese PLA General Hospital · Beijing · NCT05888909

• Huaier granule treatment for idiopathic membranous nephropathy

  This study is testing if Huaier granules can be a safe and effective treatment for people with idiopathic membranous nephropathy who haven't responded well to standard medications.

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05839314

• Treatment of advanced NK/T-cell lymphoma with selinexor and chemotherapy

  This study tests if adding a new drug called selinexor to standard chemotherapy can help people with advanced NK/T-cell lymphoma feel better and improve their treatment results.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Haidian · NCT05833893

• Comparing automated peritoneal dialysis with remote management to standard peritoneal dialysis

  This study is testing whether automated peritoneal dialysis with remote management can improve the health and quality of life for people with end-stage kidney disease compared to standard peritoneal dialysis.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05738525

• Using engineered stem cells to treat advanced solid tumors

  This study is testing a new type of stem cell treatment to see if it can help people with advanced solid tumors who haven't responded to other therapies.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing · NCT05699811

• New CAR T cell therapy for advanced solid tumors

  This study is testing a new CAR T cell therapy for people with advanced solid tumors to see if it can help fight their cancer better.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05693844

• Targeting HER2 in advanced solid tumors with modified CAR-T cells

  This study is testing a new type of CAR-T cell therapy to see if it can help people with advanced solid tumors that are HER2 positive and haven't responded to other treatments.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05681650

• Exploring the relationship between large artery atherosclerosis and small vessel disease in the brain

  This study looks at how large artery blockages and small blood vessel problems in the brain affect each other and worsen conditions like stroke and dementia, using MRI to find ways to prevent and treat these issues better.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05677607

• Imaging and analyzing blood clots in the brain

  This study is testing how brain imaging of blood clots can help doctors understand treatment outcomes for patients with blocked arteries in the brain and neck.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05663281

• Combination of CAR-DC Vaccine and Immune Checkpoint Inhibitors for Treating Malignant Tumors

  This study is testing a new vaccine combined with immune treatments to see if it can help people with advanced tumors and certain types of lymphomas fight their cancer better.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05631886

• Understanding the progression and prognosis of Moyamoya disease

  This study is trying to see how Moyamoya disease affects brain images and thinking skills over time to help improve diagnosis and treatment for patients.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05619068

• Enhanced imaging techniques for stroke diagnosis

  This study is testing whether new advanced imaging techniques can help doctors diagnose strokes faster and more accurately in patients who might have had a stroke.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05614193

• CD19-targeting CAR-γδT cell therapy for relapsed non-Hodgkin's lymphoma

  This study is testing a new treatment using special immune cells from healthy donors to see if it can help people with relapsed non-Hodgkin's lymphoma feel better.

  Recruiting at 2 sites Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT05554939

• Cochlear implants and their effects on tinnitus symptoms

  This study is testing whether cochlear implants can help reduce tinnitus symptoms in people with hearing loss by using electrical stimulation.

  Recruiting Chinese PLA General Hospital · Beijing, France · NCT05453019

• Combining surufatinib and camrelizumab with chemotherapy for advanced pancreatic cancer

  This study is testing a new combination of treatments for people with advanced pancreatic cancer to see if it works better than the standard options.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing · NCT05218889

• Ruxolitinib and chidamide–intensified busulfan/cyclophosphamide conditioning for peripheral blood stem cell transplant

  This trial tests whether adding ruxolitinib and chidamide to a busulfan/cyclophosphamide conditioning regimen helps people aged 12–65 with high‑risk B‑cell acute lymphoblastic leukemia who are receiving allogeneic peripheral blood stem cell transplants.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05088226

• Neoadjuvant chemotherapy for gastric cancer using oxaliplatin and S-1

  This study is testing if a combination of two drugs, oxaliplatin and S-1, can help people with advanced stomach cancer by shrinking their tumors before surgery.

  Recruiting Phase 3 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT04483076

• Pulmonary rehabilitation for adults on high-flow oxygen

  This test checks whether adding pulmonary rehabilitation helps adults in the ICU who are receiving high-flow humidified oxygen support.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT04441151

• Comparing microwave ablation and laparoscopic surgery for liver cancer

  This study is testing whether microwave ablation or laparoscopic surgery works better for treating liver cancer tumors that are between 3.1 and 5.0 cm in size.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT04365751

• Study on the relationship between clinical features and kidney pathology in type 2 diabetes

  This study is trying to see how the symptoms of kidney problems in people with type 2 diabetes differ from those with other kidney diseases to help improve treatment and understanding of diabetic kidney disease.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT03865914

• Anti-PD-1 antibody alone or with low-dose decitabine and chemotherapy for relapsed or refractory cancers

  This trial tests whether an anti-PD-1 immunotherapy given alone or with low-dose decitabine and chemotherapy can help people aged 12–75 whose cancers have come back or did not respond to prior treatments.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT02961101

• Combination of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

  This trial tests whether giving microwave ablation followed by immune cell therapy can help patients with small liver cancers see better outcomes.

  Recruiting Phase 2/3 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT02851784

• CD30-targeted CAR T-cell therapy for relapsed and refractory lymphomas

  This study is testing a new treatment using modified T cells to see if it can help people with relapsed or hard-to-treat Hodgkin's and Non-Hodgkin's lymphoma.

  Recruiting Phase 1/2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT02259556

Quick answers

How many clinical trials run by Chinese PLA General Hospital are recruiting right now?

133, as of November 12, 2026. 5 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 30, Phase 1/2: 25, Phase 1: 15, Phase 4: 6. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →